Organon & Co.
NYSE: OGN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Joseph T. Morrissey Jr.
- Employees
- 10,000
- Headquarters
- Jersey City, United States
- IPO year
- 2021
- Market cap
- $3.5B
- Website
- https://www.organon.com
Loading OGN…
Loading profile data…Frequently asked questions about OGN
What does Organon & Co. (OGN) do?
Organon & Co., a global pharmaceutical enterprise, is dedicated to developing and delivering a wide array of prescription therapies. Its women's health division features reproductive care products, encompassing birth control and fertility treatments, notably Nexplanon/Implanon, an extended-duration contraceptive. The company's biosimilars collec...
Where does OGN trade?
Organon & Co. (OGN) trades on the New York Stock Exchange.
What sector is OGN in?
Organon & Co. (OGN) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Organon & Co.?
Joseph T. Morrissey Jr. is the chief executive officer of Organon & Co. (OGN).
Where is Organon & Co. headquartered?
Organon & Co. is headquartered in United States.
Does OGN pay a dividend?
Yes — Organon & Co. (OGN) paid a trailing twelve-month dividend of USD 0.08 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did OGN go public?
Organon & Co. (OGN) completed its initial public offering in 2021.